International Journal of Epidemiology, Volume 33, Number 2, pp. 349-350
IJE vol.33 no.2 © International Epidemiological Association 2004; all rights reserved.
Commentary |
Commentary: Strategic surveillancekey to attainment of leprosy control and elimination goals at the local level
Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, 1600 Clifton Road Mailstop C-O9, Atlanta GA 30333, USA. E-mail: nbm8{at}cdc.gov
| The first 10% of the full text of this article appears below. |
Currently the prevalence of leprosy in six countries is still above the level of 1 per 10 000 population, defined in 1991 by the World Health Assembly as the target prevalence level for attainment of leprosy elimination.1 Together, India, Brazil, Madagascar, Mozambique, United Republic of Tanzania, and Nepal represent approximately 90% of the global leprosy burden, and new cases continue to be detected with about 620 672 registered in 2003.2 Of these, approximately 20% are at risk of developing nerve function impairment and subsequent disability, the most serious consequence of leprosy both to the patient, their family and community.3 In February 2003, the WHO